Adamas Pharmaceuticals Stock Price - ADMS

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Adamas Pharmaceuticals Inc ADMS NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.08 1.43% 5.68 5.71 5.46 5.60 5.60 11:15:32
Bid Price Ask Price Spread Spread % News
5.66 5.68 0.02 0.35% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
1,058 132,725 $ 5.62 $ 745,931 589,633 3.35 - 12.57
Last Trade Time Type Quantity Stock Price Currency
11:15:34 1 $ 5.67 USD

Adamas Pharmaceuticals Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 155.52M 27.77M $ -131.00M -4.88 - 27.07M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Adamas Pharmaceuticals News

Date Time Source News Article
11/13/201909:44Edgar (US Regulatory)Unknown (sec Staff)
11/13/201909:43Edgar (US Regulatory)Unknown (sec Staff)
11/08/201916:49Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
11/08/201916:01GlobeNewswire Inc.Adamas Announces New Employment Inducement Grant
11/07/201916:36Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)
11/07/201916:11Edgar (US Regulatory)Current Report Filing (8-k)
11/07/201916:04Edgar (US Regulatory)Quarterly Report (10-q)

Latest ADMS Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ADMS Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week4.505.713.655.39527,3121.1826.22%
1 Month4.025.713.654.57344,1501.6641.29%
3 Months6.217.783.355.35580,589-0.53-8.53%
6 Months5.527.783.355.46458,4890.162.9%
1 Year11.6312.573.357.05498,601-5.95-51.16%
3 Years16.0544.003.3519.59567,680-10.37-64.61%
5 Years14.5844.003.3519.46422,545-8.90-61.04%

Adamas Pharmaceuticals Description

Adamas Pharmaceuticals Inc discovers, develops, and sells therapies for chronic neurologic disorders. The company's approved/commercial product is GOCOVRI, an amantadine therapy for the treatment of levodopa-induced dyskinesia in patients with Parkinson's disease. It operates in one reportable segment: the development and commercialization of therapeutics targeting chronic disorders of the central nervous system. The company generates its revenues primarily from the United States.
Your Recent History
NASDAQ
ADMS
Adamas Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191114 16:33:37